Similar articles

• A multicenter clinical trial of oral ribavirin in HIV-infected people with lymphadenopathy: virologic observations. Ribavirin-LAS Collaborative Group.

  Roberts RB, Hollinger FB, Parks WP, Rasheed S, Laurence J, Heseltine PN, Makuch RW, Lubina JA, Johnson KM. Roberts RB, et al. AIDS. 1990 Jan;4(1):67-72. doi: 10.1097/00002030-199001000-00009. AIDS. 1990. PMID: 1690551 Clinical Trial.
• Open, randomized, multicentre italian trial on PEG-IFN plus ribavirin versus PEG-IFN monotherapy for chronic hepatitis C in HIV-coinfected patients on HAART.

  Cargnel A, Angeli E, Mainini A, Gubertini G, Giorgi R, Schiavini M, Duca P; Italian Co-infection Study (ICOS) Group. Cargnel A, et al. Antivir Ther. 2005;10(2):309-17. Antivir Ther. 2005. PMID: 15865225 Clinical Trial.
• Comment on Neumann et al. 'Differential antiviral effect of PEG-interferon-alpha-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients'.

  D'Offizi G, Martini F, Rozera G, Abbate I, Capobianchi MR, Narciso P, Dianzani F. D'Offizi G, et al. AIDS. 2008 Jan 11;22(2):321. doi: 10.1097/QAD.0b013e3282f323bb. AIDS. 2008. PMID: 18097242 No abstract available.
• Peginterferon-alpha-2a (40kD) plus ribavirin: a review of its use in hepatitis C Virus And HIV co-infection.

  Plosker GL, Keating GM. Plosker GL, et al. Drugs. 2004;64(24):2823-43. doi: 10.2165/00003495-200464240-00009. Drugs. 2004. PMID: 15563253 Review.
• Clinical experiences with interferon as monotherapy or in combination with ribavirin in patients co-infected with HIV and HCV.

  Puoti M, Zanini B, Bruno R, Airoldi M, Rossi S, Quiros Roldan E, El Hamad I, Moretti F, Castelli F, Sacchi P, Filice G, Carosi G. Puoti M, et al. HIV Clin Trials. 2002 Jul-Aug;3(4):324-32. doi: 10.1310/TQFQ-VA2X-95AT-H5LM. HIV Clin Trials. 2002. PMID: 12187507 Review.